Abstract
Greystone Research Associates is pleased to announce the publication of a new
market study. Injectable Drug Delivery to 2016: Drugs, Devices, Therapies,
Markets and Forecasts is a comprehensive evaluation and analysis of the
technology, products and participants providing the driving force behind this
evolving segment of the drug delivery sector. The study is designed to provide
drug company decision makers, drug delivery developers, device designers,
healthcare marketers, and supply chain participants with a detailed
understanding of the economics, technologies, disease segments, and commercial
opportunities for injectable drugs. Provider organization business managers,
healthcare administrators and investors will also benefit from this study.
Product Integration and Injectable Drug Delivery
The past decade has seen a dramatic shift in terms of the types of approved
injectable drugs, the diseases they target, and the devices used to deliver
them. This shift has fostered change on several levels of the healthcare
sector. The injectable drug segment has seen a marked increase in the level of
drug/device integration, as prefilled syringes and specialized injection
devices proliferate in response to safety and economic challenges posed by
recombinant protein drugs, while administration of injectables has moved
increasingly from practitioner offices and healthcare facilities to patient
homes. This report examines the key therapeutic, product, market and
regulatory factors for injectable drugs across ten major disease and
therapeutic classes, providing essential insight and forecasts into the
implications of this evolving landscape.
Table of Contents
Executive Summary
Injectable Drug Delivery Market Dynamics
- The Injectable Drug Ecosystem
- Injectable Drug Demand Drivers
- Drug Development Factors
- Market Factors
- Technology Factors
- Competitive Landscape
- Autoinjectors
- Needle-free Injectors
- Pen Injectors
- Prefilled Syringes
- Safety Syringes
- Injectable Drug Demand Drivers
- Diseases and Indications
- Patient Demographics
- Developing Economies
- Risks and Opportunities
Injectable Drug Device Selection Criteria
- Stability and Material Selection Issues
- Single vs Multi-Dose Devices
- Lyophilized Drugs/Reconstitution
- Syringe Safety/Sharps Protection
- Needle Configuration Strategies
- Disposable Drug Cartridges
- Human Engineering/Ergonomics
- Branding/Private Labeling
Injectable Drug Delivery - Device Segments
- Autoinjectors
- Autoinjector-specific Selection Factors
- Part Counts and Device Cost
- Safety Features
- Needle Shielding
- Needle Insertion Depth
- Failsafe Activation
- Dose Inspection/Injection Confirmation
- Autoinjector Device Categories
- Reusable Autoinjectors
- Disposable Autoinjectors
- Product Specific Autoinjectors
- Drugs and Therapeutic Segments
- Needle-free Injectors
- Device Categories
- End User/Practitioner/Mass Immunization Injectors
- Prefilled Disposable Models
- Refillable Cartridge Designs
- Needle-free Injector-specific Selection Factors
- Energy Source
- Injection Site Selection
- Pen Injectors
- Pen Injector Device Categories
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Branded Drug/Pen Injector Product by Therapeutic Segment
- Prefilled Syringes
- Prefilled Syringe Device Categories
- Glass Prefilled Syringes
- Prefillable Glass Syringe Manufacturers and Branded Devices
- Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
- Plastic Prefilled Syringes
- Branded Prefillable Plastic Syringes
- Drugs and Therapeutic Segments
- Prefillable Safety Syringes
- Prefilled Syringe-specific Selection Factors
- PFS Manufacturing Factors
- Fill-and-Finish Operations
- Safety Syringes
- Safety Syringe Device Categories
- Prefillable Integrated Safety Syringes
- Non-Prefillable Integrated Safety Syringes
- Retractable Needle
- Manually Retractable
- Automatic Retractable
- Sliding Sheath
Injectable Drug Delivery - Therapeutic Segment Analysis & Forecasts
- Anaphylaxis
- Anticoagulants
- Antivirals
- Autoimmune Diseases
- Emergency Medicine
- Hematopoietics
- Hormone Replacement
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines
Injectable Drug Therapeutics - Market Factors
- Regulatory Factors and Issues
- FDA Regulations
- Regulating Combination Products
- Sharps Legislations
- Growth and Diversity of Safety Syringes
- Sharps Disposal
- Clinical Trial Factors
- Managed Care and Healthcare Economics
Company Profiles
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
